SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Kirk Sigurd

(Last)

(First)

(Middle)

225 SUMMIT AVENUE

(Street)

MONTVALE

07645

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/04/2008

3. Issuer Name and Ticker or Trading Symbol
BARR PHARMACEUTICALS INC [ BRL ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Sr VP Finance & Corp Controlle

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	1,064	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Incentive Stock Options	08/04/2006	08/04/2013	Common Stock	1,500	$44.6333	D
Incentive Stock Options	⁽¹⁾	08/04/2014	Common Stock	2,444	$35.01	D
Non-Qualified Stock Options	08/04/2006	08/04/2014	Common Stock	556	$35.01	D
Incentive Stock Options with Tandem SARs	⁽²⁾	07/27/2015	Common Stock	3,010	$46.99	D
Stock Appreciation Rights	⁽³⁾	07/27/2015	Common Stock	2,990	$46.99	D
Incentive Stock Options with Tandem SARs	⁽⁴⁾	07/26/2016	Common Stock	2,172	$48.8	D
Stock Appreciation Rights	⁽⁵⁾	07/26/2016	Common Stock	12,828	$48.8	D
Incentive Stock Options with Tandem SARs	03/07/2010	03/07/2017	Common Stock	2,020	$49.49	D
Stock Appreciation Rights	⁽⁶⁾	03/07/2017	Common Stock	9,980	$49.49	D

Explanation of Responses:

1. 944 vested on 8/4/2006 1,500 vested on 8/4/2007

2. 1,010 vested on 7/27/2007 2,000 vest on 7/27/2008

3. 2,000 vested on 7/27/2006 990 vested on 7/27/2007

4. 123 vest on 7/26/2008 2,049 vest on 7/26/2009

5. 5,000 vested on 7/26/2007 4,877 vest on 7/26/2008 2,951 vest on 7/26/2009

6. 4,000 vest on 3/7/2008 4,000 vest on 3/7/2009 1,980 vest on 3/7/2010

Remarks:

	S/S William T McKee as Attorney-in-Fact for Sigurd Kirk	03/13/2008
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.